pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

12,459 catalysts · 3,431 8k filing · 2,370 grant · 1,843 approval · 1,245 device 510k · 1,000 device adverse event · 880 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 0 catalysts2026-08-19: 30 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-11-21×clear all
type
  • 8k filing3,431
  • grant2,370
  • approval1,843
  • device 510k1,245
  • device adverse event1,000
  • device pma880
device recall
718
  • earnings584
  • recall307
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Dec 8, 2025

    50
    ›Dec 8, 2025device recall255d agoBeckman Coulter Ireland, Inc. device recall (Cls II)

    The LDL-Cholesterol assay is comprised of two distinct phases. In phase one a unique detergent solubilizes cholesterol from non-LDL- lipoprotein particles. This cholesterol is consumed by cholesterol esterase, cholesterol oxidase, peroxidase and 4- aminoantipyrine to generate a colorless end product. In phase two a second detergent in reagent 2 releases cholesterol from the LDL lipoproteins. This cholesterol reacts with cholesterol esterase, cholesterol oxidase and a chromogen system to yield a blue color complex which can be measured bichromatically at 540/660nm. The resulting increase in absorbance is directly proportional to the LDL-C concentration in the sample. — Reason: Beckman Coulter identified that LDL Cholesterol OSR6x96 is not meeting the performance claim listed in the Instructions for Use (IFU). LDL Cholesterol reagent showed clinically significant interference due to triglyceride concentration up to 1500 mg/dL may cause a maximum positive bias of up to 28.8% in low LDL Cholesterol samples (concentration 80 mg/dL) and up to 11.02% in high LDL Cholesterol samples (concentration 160mg/dL). — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 8, 2025device recall255d agoSecuritas Healthcare LLC device recall (Cls II)

    Arial 900 MHz Call Station, Model Number CSK200-900MR, with Firmware version: 1.6.3 — Reason: Securitas Healthcare has become aware of a firmware issue in the Call Stations in the Affected Lots that may cause Call Stations in the Affected Lots to (1) not transmit a low battery alert to the Arial Wireless Emergency Call System prior to battery failure, or (2) not transmit a low battery alert to the Arial Wireless Emergency Call system at least seven (7) days prior to the battery failing. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 8, 2025device recall255d agoSecuritas Healthcare LLC device recall (Cls II)

    Arial 900 MHz Call Station, Model Number CSK200-900, with Firmware version: 1.6.3 — Reason: Securitas Healthcare has become aware of a firmware issue in the Call Stations in the Affected Lots that may cause Call Stations in the Affected Lots to (1) not transmit a low battery alert to the Arial Wireless Emergency Call System prior to battery failure, or (2) not transmit a low battery alert to the Arial Wireless Emergency Call system at least seven (7) days prior to the battery failing. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

    Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

    Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

    Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoRYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approvalrozanolixizumab

    Sponsor: UCB INC. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →rozanolixizumab →fda approvals ↗
    ›Dec 9, 2025approval254d agoIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    ›Dec 9, 2025approval254d agoRECARBRIO (CILASTATIN SODIUM) — FDA approval(cilastatin sodium + imipenem + relebactam)

    Sponsor: MSD MERCK CO. Form: POWDER. Route: INTRAVENOUS

    full page →(cilastatin sodium + imipenem + relebactam) →fda approvals ↗
    ›Dec 9, 2025approval254d agoTEPYLUTE (THIOTEPA) — FDA approvalSTI Pharma LLC

    Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoTEPYLUTE (THIOTEPA) — FDA approvalSTI Pharma LLC

    Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 9, 2025approval254d agoIMITREX (SUMATRIPTAN) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    ›Dec 9, 2025approval254d agoIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    ›Dec 9, 2025approval254d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Dec 9, 2025approval254d agoVECURONIUM BROMIDE — FDA approvalVECURONIUM BROMIDE

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →VECURONIUM BROMIDE →fda approvals ↗
    ›Dec 9, 2025device 510k254d agoFocused Cryo, Inc. — Focused Cryotherapy System (510k cleared)

    Product code: GEH. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 9, 2025device 510k254d agoGE Medical Systems SCS — Allia Moveo (510k cleared)

    Product code: OWB. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 9, 2025device 510k254d agoShofu Dental Corporation — GlasIonomer FX-LC (510k cleared)

    Product code: EMA. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 9, 2025device 510k254d agoDevilbiss Healthcare, LLC — DeVilbiss PulmO2 10-Liter Oxygen Concentrator (1060AW) (510k cleared)

    Product code: CAW. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 9, 2025device 510k254d agoGuangzhou Longest Medical Technology Co., Ltd. — Portable Electro Stimulation Therapy Device (LGT-2320BE, LGT-2320ME, and LGT-2320SP) (510k cleared)Guangzhou Dazhou Biomedical Technology Co Ltd

    Product code: NGX. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 9, 2025device 510k254d agoTianjin Huahong Technology Co., Ltd. — Lancing device (HH-XV-T) (510k cleared)

    Product code: QRL. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Dec 9, 2025device 510k254d agoInfinitt Healthcare Co., Ltd. — INFINITT DPS (510k cleared)NVP Healthcare Co Ltd

    Product code: QKQ. Advisory committee: Pathology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 9, 2025device 510k254d agoDentsply Sirona — Atlantis® Abutments in Titanium (510k cleared)DENTSPLY SIRONA Inc.

    Product code: NHA. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 9, 2025device pma254d agoAbbott Vascular, Inc. — XACT® Carotid Stent System (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: NIM. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoZoll Manufacturing Corporation — LifeVest® Wearable Defibrillator (PMA supplement)

    Supplement type: Real-Time Process. Product code: MVK. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoDepuy, Inc. — LCS® Total Knee System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoAbbott Vascular, Inc. — Perclose ProGlide® Suture-Mediated Closure System; Prostar® XL Percutaneous Vascular Surgical System (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: MGB. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoZOLL Medical Corporation — ZOLL Zenix Monitor/Defibrillator; ZOLL Zenix Multi-function Cable; ZOLL Zenix CPR Complete Electrodes; ZOLL OneStep Paci (PMA supplement)

    Supplement type: Real-Time Process. Product code: MKJ. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoDePuy Orthopaedics, Inc. — Ceramax Ceramic Hip System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MRA. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoAbbott Vascular Devices — StarClose SE® Vascular Surgical System (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: MGB. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoABBOTT MEDICAL — Tendril STS Leads; Ultipace Leads (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoABBOTT MEDICAL — Durata Leads; Optisure Leads (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoProverum, Ltd. — ProVee System for BPH (PMA)

    Product code: MER. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Dec 9, 2025device pma254d agoAbbott Vascular (Idef Technologies Inc) — Supera™ Peripheral Stent System (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: NIP. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Dec 9, 2025device recall254d agoIntuitive Surgical, Inc. device recall (Cls II)INTUITIVE SURGICAL INC

    Brand Name: da Vinci S, Si Permanent Cautery Hook Instrument Product Name: da Vinci S, Si Permanent Cautery Hook Instrument Model/Catalog Number: 420183 Software Version: NA Product Description: EndoWrist Instruments or da Vinci S/Si Reusable instruments, including blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pick-ups, needle holders, endoscopic retractors, electrocautery and accessories are intended for endoscopic manipulation of tissue, including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, and delivery and placement of microwave and cryogenic ablation probes and accessories. Please refer to attached User Manual for additional details on intended use. All da Vinci S/Si reusable instruments with jaws use mechanical tungsten cables and pulleys to transmit motion from the input discs to the housing (on the proximal chassis), through the main shaft, and the distal instrument tip (inside the patient). Component: NA — Reason: Due to increased in complaints regarding frayed or broken pitch cables on reusable surgical instruments — Status: Ongoing

    full page →fda device recalls ↗
    ← prev
    page 12 of 250
    next →
    $AMRX18.190.00%
    $ANIP78.02+1.50%
    $AMRX18.190.00%
    $AMRX18.190.00%
    $ANIP78.02+1.50%
    $ANIP78.02+1.50%
    $ANIP78.02+1.50%
    $ONC376.86+2.09%
    $AMRX18.190.00%
    $AMRX18.190.00%
    $ONC376.86+2.09%
    $MRK152.23+12.62%
    $ONC376.86+2.09%
    $XRAY11.15+0.41%
    $ISRG400.12+2.29%